Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xenon and Therapeutical Hypothermia After Successful Cardiopulmonary Resuscitation
NCT01262729Phase 2Terminated
- Sponsor
- RWTH Aachen University
- Start
- Sep 2011
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of xenon in cardiac arrest (SCA) (2 arms), sponsored by RWTH Aachen University. Primary endpoint: Significant difference between treatment group and control group at 28 days. Started Sep 2011; status: terminated.
02
Drugs
xenon
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on NCT01262729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01262729.